Insights

More Articles Back to Article

EU clears Saladax's clozapine test

European regulators have granted CE mark approval to Saladax Biomedical's MyCare Insite Clozapine test for use in treating and monitoring patients with schizophrenia. The point-of-care assay provide accurate and precise clozapine blood levels by testing capillary blood on the MyCare Insite platform. 360Dx (tiered subscription model) (9/5)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!